Narrow search
Showing 1 - 10 of 10,048
Cover Image
Optimal patent policy for pharmaceutical industry
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2020
Persistent link: https://www.econbiz.de/10012439514
Cover Image
Patent Protection, Creative Destruction, and Generic Entry in Pharmaceuticals : Evidence from Patent and Pricing Data
Marco, Alan C. - 2006
This paper merges patent citation data with data on pharmaceutical patent expirations, generic entry, and pricing to explore the effects of observable patent characteristics on off-patent and on-patent pharmaceutical pricing. Using a sample of drug patents facing generic entry in the 1990s, I...
Persistent link: https://www.econbiz.de/10012732596
Cover Image
Prices and related controversies in the biopharmaceutical industry
Manning, Richard L. - In: International journal of the economics of business 25 (2018) 1, pp. 157-166
Persistent link: https://www.econbiz.de/10011881466
Cover Image
Copyright and Trademark Issues in the Pharmaceutical Industry : Generic Compliance or Brand Drug Imitating: 'Copycat or Compliance'
Termini, Roseann B.; Miele, Amy - 2014
Imitation is the sincerest form of flattery; that is, unless the imitation is of a product produced by a multi billion-dollar industry. Then, imitation has the potential to involve intellectual property litigation. For the pharmaceutical industry, the majority of intellectual property litigation...
Persistent link: https://www.econbiz.de/10014161252
Cover Image
Product patents and access to innovative medicines in a post-trips-era
Watal, Jayashree; Dai, Rong - 2019 - Manuscript date: 28 March 2019
This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era … the introduction of product patents in pharmaceuticals affect the likelihood of pharmaceutical firms to launch new and … finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood …
Persistent link: https://www.econbiz.de/10011992779
Cover Image
Optimal incentives for patent challenges in the pharmaceutical industry
Böhme, Enrico; Frank, Jonas Severin; Kerber, Wolfgang - In: Review of industrial organization 59 (2021) 3, pp. 503-528
Persistent link: https://www.econbiz.de/10012659758
Cover Image
Optimal incentives for patent challenges in the pharmaceutical industry
Böhme, Enrico; Frank, Jonas Severin; Kerber, Wolfgang - 2017
Since the patent system relies on private litigation for challenging weak patents, and patent settlements might influence the incentives for challenging patents, the question arises whether the antitrust assessment of patent settlements should also consider their impact on the incentives to...
Persistent link: https://www.econbiz.de/10011579217
Cover Image
Impact of product patents on pharmaceutical market structure and prices in India
Chaudhuri, Sudip - 2018
Persistent link: https://www.econbiz.de/10011963838
Cover Image
Patents, trade and medicines : past, present and future
Shadlen, Kenneth C.; Sampat, Bhaven N.; Kapczynski, Amy - In: Review of international political economy 27 (2020) 1, pp. 75-97
Persistent link: https://www.econbiz.de/10012208081
Cover Image
The new political economy of pharmaceuticals : production, innnovation and TRIPS in the global south
Löfgren, Hans (contributor) - 2013
"Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its rules on pharmaceutical patents. This volume is the...
Persistent link: https://www.econbiz.de/10009793209